Skip to main navigation Skip to search Skip to main content

Omega‐3 fatty acids and/or fluvastatin in hepatitis C prior non‐responders to combination antiviral therapy – a pilot randomised clinical trial

  • David A. Sheridan*
  • , Simon H. Bridge
  • , Mary M.E. Crossey
  • , Daniel J. Felmlee
  • , Fiona I. Fenwick
  • , Howard C. Thomas
  • , R. Dermot G. Neely
  • , SD Taylor‐Robinson
  • , Margaret F. Bassendine
  • *Corresponding author for this work
  • Newcastle University
  • Northumbria University
  • Imperial College London
  • Institut national de la santé et de la recherche médicale
  • Newcastle upon Tyne Hospitals NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Omega‐3 fatty acids and/or fluvastatin in hepatitis C prior non‐responders to combination antiviral therapy – a pilot randomised clinical trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science